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Degradation of buffalo &casein by various physioIogica1 enzymes was studied. Digestion with gastric and 
pancreatic proteases plus leucine aminopeptidase did not release casomorphins but a putative precursor 
(procasomorphin) which was further digested by brush border peptidases into peptides differing from 
casomorphins. 
Casomorphin Brush border protease Casein sigh-performance Iiquid chromatography 
1, INTRODUCTION 2. MATERIALS AND METHODS 
Authors in [I] have shown the presence of 
opioid materiafs in bovine milk and milk products. 
Authors in [2] isolated from casein peptone (an 
undefined enzymatic digest of bovine whole ca- 
sein) an opioid peptide resistant to pronase. The 
sequence of this peptide, ,&casomorphin 7, cor- 
responds to the sequence 60-66 of bovine #-casein 
and seems to be of general occurrence in all the& 
caseins so far investigated, i.e., bovine [3], ovine 
[4j and buffalo [5]. 
2.1. Materials 
Buffalo ,&casein was isolated from whole casein 
as in [6]. Rabbit small intestine brush border was 
obtained as in 171. Peptidase activities were assayed 
as in [8]; working solutions were prepared with a 
total activity of 1.5 units/ml aminopeptidase N,
2.0 units/ml aminopeptidase A and 0.5 units/ml 
dipeptidyl aminopeptidase IV. ~-Casomorphin 7
and proteases were purchased from Sigma. 
However, it is not clear whether &casomorphin 
could be released in the gastrointestinal tract and 
reach concentrations of physiological significance 
~-casomorphin is 250-times less potent than nor- 
morphin [Z]). Thus, whether this peptide plays a 
physiological or toxicological role is an open 
question. 
2.2. Enzyme digestions and separation of peptides 
Buffalo &casein (500 mg), in 50 ml aqueous 
We have undertaken a study to answer this ques- 
tion. We report here preliminary results obtained 
by studying in vitro proteolysis of buffalo @-casein 
by gastric, pancreatic and brush border proteases 
plus leucine aminopeptidase. 
solution of 30% acetic acid, was first hydrolysed 
with pepsin (5 mg). A long incubation time (5 h) 
was required because of the poor solubility of the 
protein at acidic pH. The pH of the digest was then 
adjusted to 8.5 with ammonium hydroxide and at 
intervals of 1 h trypsin (4 mg), chymotrypsin 
(4 mg), elastase (4 mg), carboxypeptidase A 
(1 mg), carboxy~ptidase B (1 mg) and leucine 
aminopeptidase (1 mg) were added. One h after 
the last addition the digest (GPE digest) was direct- 
ly analysed by HPLC. 
Abbreviation: GPE, gastric and pancreatic enzymes plus 
leucine aminopeptidase 
Purified peptides (150 nmol) were incubated in 
0.1 M ammonium bicarbonate (pH 8) with 75 ~1 of 
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brush border preparation. Aliquots of this mix- 
ture, at the times indicated, were acidified with 
glacial acetic acid and analysed by HPLC. Pep- 
tides were purified either on a Waters liquid 
chromatograph equipped with two pumps (model 
6600 A), a solvent programmer (model 660) and a 
variable wavelength UV detector (model 450) or on 
a Beckman liquid chromatograph equipped with 
two pumps (model llO), a solvent programmer 
(model 420) and a variable wavelength UV detector 
(model 100-40 Hitachi). A p-Bondapak C-18 
reverse-phase column (5 pm, 4.6 x 250 mm) was 
used. Peptides were eluted at a flow rate of 
1 ml/min with a gradient of CH&N in 0.1% 
trifluoroacetic acid as indicated in fig.1. Details 
for amino acid analysis were as reported in [5]. 
3. RESULTS AND DISCUSSION 
3.1. GPE digest 
Fig.1. shows the HPLC pattern of the GPE 
digest of buffalo fl-casein in comparison with that 
0 
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," .04. 
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obtained by running the same sample spiked with 
&casomorphin 7. It is evident that the gastric and 
pancreatic proteases used here are unable to release 
,&casomorphin 7 from ,&-casein. 
Furthermore from the GPE digest a pure peptide 
was isolated (peak P in fig.la). This peptide, 
whose amino acid composition is reported in table 
1, corresponds to the sequence positions 59-68 of 
buffalo &casein [5] and contains fl-casomorphin. 
We shall henceforth refer to this peptide as pro- 
casomorphin. It should be noted that Lys 68 in 
buffalo ,&casein [5] replaces Asn 68 in cow p- 
casein [3]. 
3.2. Brush border digest 
Procasomorphin was digested by brush border 
enzymes for 0.5, 1 and 4 h and the digest analysed 
by HPLC (fig.2). A blank run without peptide 
shows that peaks X and Y arise from the brush 
border preparation. It is evident that digestion of 
procasomorphin by brush border proteases gives 
rise to peptides A-C. Table 1 lists the composi- 
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Fig. 1. HPLC chromatograms of GPE digest (for details see section 2) with (b) and without (a) ,8-casomorphin. ,8, ,8- 
casomorphin 7; P, procasomorphin. 
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Table 1 
Amino acid compositions of peptides purified from 
GPE and brush border digest 
Peptide Amino acid composition 
Procasomorphin (fig. 1) Pro(3.7),Gly(l .O),Va1(0.9), 
Ile( 1 .O),Tyr(O.8),Phe( 1 .O), 
Lys(O.8) 
Peptide A (fig,2a--c) Pro{1 .Z),Tyr(O.9),Phe( 1 .O) 
Peptide B (fig.2a,b) Pro(3.9),GIy(l.O),Ile(0.8), 
Tyr(O.(i),Phe(O.9) 
Peptide C (fig.2a) Pro(4,3),Gly( 1.2),Val(l .O), 
Ile(1 .O),Tyr(O.8),Phe(O.9) 
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Fig-Z. HPLC pattern of brush border digest of 
procasomorphin at 0.5 (a), 1 (b) and 4 h (c). Conditions 
were as in fig.1. Peaks X and Y arise from the brush 
border preparation; for the identification of peptides 
A-C refer to table 1 and fig.3. The arrow indicates the 
retention time of proc~omorphin. 
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Fig.3. Amino acid sequence of procasomorphin. The 
sites of brush border protease hydrolysis are indicated by 
arrows. The sequence of ,&casomorphin s boxed. 
tions of purified peptides from which the se- 
quences shown in fig.3 have been inferred. Under 
our experimental conditions we were not able to 
detect ,&casomorphin 7 which could be putatively 
split from procasomorphin by the action of brush 
border amino- and carboxypeptidase activities. 
In fig.3 the amino acid sequence of procasomor- 
phin and the putative sites of hydrolysis by brush 
border proteases are reported. It is worth noting 
that peptide B purified from brush border digest at 
0.5 and 1 h of incubation (fig.2a,b) differs from 
casomorphin 7 in having an additional proline 
residue at the C-terminal. The brush border car- 
boxypeptidase activity which removes the C- 
terminal lysine from procasomorphin seems to be 
unable to remove the following proline residue. 
Furthermore, the presence of the peptide A (Tyr- 
Pro-Phe) at 0.5 h wouId indicate an endopeptidase 
as the major cause of the complete degradation of 
procasomorphin at 4 h of incubation. 
The results can be summarized as follows: 
(i) Proteolytic enzymes of gastrointestinal tract 
plus Ieucine aminopeptidase, under controlled 
conditions, do not release ~-casomorphin 7 
from &casein but a putative precursor, i.e., 
procasomorphin; 
(ii) Procasomorphin is further digested by brush 
border peptidases but not to casomorphin; 
(iii) The peptide Tyr-Pro-Phe still resistant o pro- 
teolytic activity of the brush border is devoid 
of any opioid activity [9]. 
Apparently our results seem then to exclude a 
physiological role for ,&casomorphin. However, 
only in vivo studies would unequivocally clarify 
whether fi-casomorphin is of any physioiogical 
significance. 
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